Prevention strategies for prostate cancer

被引:0
|
作者
Schmitz-Draeger, B. J. [1 ]
Luemmen, Q. [2 ]
Bismarck, E. [1 ]
Fischer, C. [3 ]
机构
[1] EuromedClinic, Furth, Germany
[2] St Josef Hosp, Dept Urol, Troisdorf, Germany
[3] Klinikum Hohe Warte, Urol Clin, Bayreuth, Germany
关键词
Prostatic neoplasms; Primary prevention; Vitamins; Nutrition; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BODY-MASS INDEX; PHYSICAL-ACTIVITY; BLADDER-CANCER; TRIAL SELECT; FOLLOW-UP; VITAMIN-E; RISK; METAANALYSIS; NUTRITION;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Through the last decade consideration of the role of vitamins and minerals in primary prevention of genitourinary tumors has dramatically changed. Despite all efforts efficacy of a specific compound has not been proven, so far. In consequence, recommendations for a use of vitamins or other supplements with the intention of prostate cancer prevention should be avoided today. In contrast, there is some evidence that life style modification might be helpful: recent investigations suggest that smoking may be involved in prostate cancer carcinogenesis. In addition, there is evidence that moderate food consumption, reduction of dairy products and an Asian or Mediterranean diet might not only prevent prostate cancer but also harbors additional beneficial effects on general health. This move from single compounds to more complex diets can be considered as, a change of paradigm in prostate cancer prevention and could be the starting point of future epidemiological research. Disappointing findings with regards to nutritional cancer prevention contrast with a solid evidence concerning the efficacy of chemoprevention using 5a-reductase inhibitors: Long-term use of Finasteride and Dutasteride significantly reduces prostate cancer detection. Further candidate drugs are under investigation. However, translation of these findings into urological practice remains a matter of controversial discussion.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 50 条
  • [21] The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention
    Nelson, WG
    De Marzo, AM
    DeWeese, TL
    UROLOGY, 2001, 57 (4A) : 39 - 45
  • [22] Diet and prostate cancer prevention
    Marshall, James R.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 157 - 165
  • [23] Bone prevention in prostate cancer
    Bessede, Th
    PROGRES EN UROLOGIE, 2011, 21 : S58 - S62
  • [24] Epidemiology and Prevention of Prostate Cancer
    Gandaglia, Giorgio
    Leni, Riccardo
    Bray, Freddie
    Fleshner, Neil
    Freedland, Stephen J.
    Kibel, Adam
    Stattin, Par
    Van Poppel, Hendrick
    La Vecchia, Carlo
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (06): : 877 - 892
  • [25] Prevention of prostate cancer with finasteride
    Barzell, WE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16): : 1571 - 1572
  • [26] The future of prostate cancer prevention
    Brawley, OW
    Barnes, S
    Parnes, H
    CANCER PREVENTION: MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS, 2001, 952 : 145 - 152
  • [27] Hormonal prevention of prostate cancer
    Brawley, OW
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 67 - 72
  • [28] Finasteride for prevention of prostate cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1289): : 49 - 50
  • [29] Aspirin and prostate cancer prevention
    Vidal, Adriana C.
    Freedland, Stephen J.
    AGING-US, 2015, 7 (05): : 292 - 293
  • [30] Prostate cancer: Epidemiology and prevention
    Albanes, D
    CANCER & NUTRITION PREVENTION AND TREATMENT, 2000, 4 : 55 - 65